Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Lung Cancer Screening Center Offers Early Detection with Multidisciplinary Approach

By HospiMedica International staff writers
Posted on 21 Aug 2012
A pioneering, comprehensive lung cancer screening center offers more effective early detection services by reliance on computed tomography (CT) scan over chest X-rays for screening and by drawing on the world-class expertise of its multidisciplinary team.

New York University Langone Medical Center (NYU Langone; New York City, NY, USA) radiologists have used computed tomography (CT) scans for lung cancer screening since the 1990s and, with collaborators at Cornell University Medical Center, published the original study on CT screening to detect early lung cancer in 2000. More...
More recently, a National Cancer Institute-sponsored study published in the New England Journal of Medicine (NEJM) in 2011 revealed that screening of heavy smokers with CT can decrease lung cancer mortality by 20 percent compared with chest X-ray.

"Research shows that using CT scans to screen the lungs of people at higher risk of lung cancer led to early detection and saved lives. Certain patients, especially current and former smokers, would greatly benefit from this,” said Harvey I. Pass, MD, Stephen E. Banner professor of Thoracic Oncology, Departments of Surgery and Cardiothoracic Surgery, Division of Thoracic Surgery, and a Principle Investigator in the Early Detection Research Network (EDRN) of the National Cancer Institute. Most lung cancers are still discovered at late stages, when treatment is more challenging. CT screening often allows the diagnosis of lung cancer at its earliest and most treatable stages.

Since 2000 NYU Langone has been a part of the National Cancer Institute Early Detection Research Network (EDRN) - which includes dozens of institutions to help accelerate the translation of biomarker information into clinical applications and to evaluate new ways of testing cancer in its earliest stages and for cancer risk. NYU Langone also offers individuals at risk the chance to undergo a low-dose CT scan to evaluate for signs of early lung cancer as well as to participate in a National Cancer Institute-funded lung cancer early detection study.

Related Links:

New York University Langone Medical Center
NYU Langone Medical Center Lung Cancer Screening Program



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.